Salmonella Effector SpvC Targets SEC23B of Intestinal Epithelial Cells to Resist Gasdermin D-Mediated Protection Against Systemic Infection

Salmonella infects a wide range of hosts, causing gastroenteritis or systemic infection in humans and animals, highlighting the urgent need for a deeper understanding of its pathogenesis. SpvC, a critical virulence determinant of salmonella, facilitates bacterial dissemination. Gasdermin D (GSDMD) is the only gasdermin known to protect mice against acute Salmonella enteritis. Our preliminary findings indicated that SpvC counteracts GSDMD-mediated antibacterial effects to enhance bacterial dissemination, although its functional relevance to epithelial-derived GSDMD and the underlying mechanisms remain unclear. To address this, Gsdmd−/− C57BL/6J and wild-type mice were infected with Salmonella Typhimurium (S. Typhimurium) wild-type strain and spvC deletion mutant. Our results demonstrate that SpvC compromises intestinal epithelial barrier integrity, overcoming GSDMD-mediated protection against systemic infection. Specifically, through bioinformatics analysis, LC-MS/MS, and in vivo experiments with Caco-2 cell monolayers and site-directed spvC mutants, we identified SEC23B as a novel target of SpvC. This interaction disrupts the intestinal epithelial barrier through the autophagy–pyroptosis pathway. This study identifies SEC23B as a unique cellular target of SpvC involved in GSDMD activation during S. Typhimurium systemic infection. It also reveals a novel mechanism by which Salmonella evades host defense mechanisms.